Halyk Bank of Kazakhstan Joint Stock Company (HSBK)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 32.50 |
|---|---|
| 52-week range | 22.90 – 36.45 |
| Return, 1 month / 3 months | −3.7% / +8.2% |
| Return, 1 year / 3 years | +43.2% / +320.5% |
| Trend | Above 200-day, below 50-day |
| RSI (14) | 42 |
| Volatility (1 year) | 23.6% |
| Worst drawdown (1 year) | -12.8% |
| Average daily value traded | 1.71M USD |
| Dividend yield | – |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Halyk Bank of Kazakhstan is a commercial bank based in Kazakhstan that serves individuals, businesses and corporate clients. It offers everyday banking such as savings and current accounts, payment cards, mortgages and consumer loans, alongside lending, trade finance and cash management for companies. The bank also provides insurance and pension-related services through its group. Its customers are mainly households and enterprises in Kazakhstan, and it operates a branch and digital network across the country.
Halyk Bank of Kazakhstan Joint Stock Company trades under the code HSBK on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 8 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Halyk Bank of Kazakhstan Joint Stock Company (HSBK) trades on the London Exchange in UK. It last closed at USD 32.50 on 23 October 2026.
Its price-based Market X-Ray is 76 out of 100 (a strong price profile), ranking 213 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 43.2% and over the last three months it rose 8.2%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 77 · Strong | Trading above its long-term averages and near its highs. | |
| Above 200-day average | 9.3% | ||
| From 52-week high | -9.1% | ||
| Momentum | 75 · Strong | Rising faster than most stocks on this exchange. | |
| 3-month return | 8.2% | ||
| 6-month return | 6.6% | ||
| 12-month return, skipping the last month | 48.7% | ||
| Stability (higher is calmer) | 85 · Strong | Calmer than most: low volatility and shallow drawdowns. | |
| Volatility, 1 year (lower is calmer) | 23.6% | ||
| Worst drawdown, 1 year (smaller is calmer) | -12.8% | ||
| Liquidity | 58 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.71M USD | ||
| Zero-volume days | 0.0% | ||
| Income | – | Pays no dividend. | |
| Dividend yield | – | ||
| Years with dividends | 5 |
Strengths
- Trend: Trading above its long-term averages and near its highs.
- Momentum: Rising faster than most stocks on this exchange.
- Stability (higher is calmer): Calmer than most: low volatility and shallow drawdowns.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −1.5% |
|---|---|
| 1 month | −3.7% |
| 3 months | +8.2% |
| 6 months | +6.6% |
| 1 year | +43.2% |
| 3 years | +320.5% |
| 5 years | +287.2% |
Signals
| 50-day / 200-day average | 33.28 / 29.74 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.88 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 25 Aug 2026 | KZT 2.3973 |
| 29 Apr 2026 | KZT 2.5105 |
| 22 Sep 2025 | KZT 1.5154 |
| 2 May 2025 | KZT 2.2491 |
| 12 Dec 2024 | KZT 0.7291 |
| 14 May 2024 | KZT 2.2389 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.